Lee, J. W., Gu, H., Jung, Y., Jung, Y., Seo, S., Hong, J., . . . Oh, B. (2023). Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation. Nature Publishing Group.
Chicago-Zitierstil (17. Ausg.)Lee, Jin Wook, et al. Candesartan, an Angiotensin-II Receptor Blocker, Ameliorates Insulin Resistance and Hepatosteatosis by Reducing Intracellular Calcium Overload and Lipid Accumulation. Nature Publishing Group, 2023.
MLA-Zitierstil (9. Ausg.)Lee, Jin Wook, et al. Candesartan, an Angiotensin-II Receptor Blocker, Ameliorates Insulin Resistance and Hepatosteatosis by Reducing Intracellular Calcium Overload and Lipid Accumulation. Nature Publishing Group, 2023.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.